- Report
- April 2024
- 305 Pages
Global
From €5299EUR$6,010USD£4,350GBP
- Report
- February 2024
- 264 Pages
Global
From €5299EUR$6,010USD£4,350GBP
- Report
- December 2023
- 408 Pages
Global
From €5299EUR$6,010USD£4,350GBP
- Report
- February 2023
- 276 Pages
Global
From €4811EUR$5,457USD£3,950GBP
- Report
- December 2022
- 437 Pages
Global
From €4811EUR$5,457USD£3,950GBP
- Report
- March 2025
- 84 Pages
Global
From €400EUR$470USD£352GBP
- Report
- April 2024
- 270 Pages
Global
From €4563EUR$5,000USD£3,877GBP
- Report
- May 2023
- 261 Pages
Global
From €4563EUR$5,000USD£3,877GBP
- Report
- February 2022
- 272 Pages
Global
From €5475EUR$6,000USD£4,652GBP
- Report
- January 2022
- 109 Pages
Global
From €2738EUR$3,000USD£2,326GBP
- Report
- December 2019
- 59 Pages
Global
From €3650EUR$4,000USD£3,101GBP
- Drug Pipelines
- May 2022
- 400 Pages
Global
From €2738EUR$3,000USD£2,326GBP
- Report
- November 2022
- 150 Pages
Global
From €4426EUR$4,850USD£3,761GBP
- Report
- January 2024
- 293 Pages
Global
From €4517EUR$4,950USD£3,838GBP
- Report
- May 2023
- 147 Pages
Global
From €4243EUR$4,650USD£3,605GBP
- Report
- May 2022
- 335 Pages
Global
From €5019EUR$5,500USD£4,265GBP
- Report
- December 2021
- 353 Pages
Global
From €5019EUR$5,500USD£4,265GBP
- Report
- March 2024
- 738 Pages
Global
From €4517EUR$4,950USD£3,838GBP
- Report
- February 2024
- 379 Pages
Global
From €4517EUR$4,950USD£3,838GBP
- Report
- January 2024
- 483 Pages
Global
From €6524EUR$7,150USD£5,544GBP

Cell therapy is a type of biotechnology that involves the use of living cells to treat or prevent a disease. It is a rapidly growing field of medicine that has the potential to revolutionize the way diseases are treated. Cell therapy involves the use of living cells, either from the patient or from a donor, to replace or repair damaged cells or tissues. This can be done through the use of stem cells, gene therapy, or other cell-based therapies. Cell therapy has the potential to treat a wide range of diseases, including cancer, heart disease, diabetes, and neurological disorders.
Cell therapy is a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Novartis, Celgene, and Kite Pharma are leading the way in developing cell therapies for a variety of diseases. Other companies such as Gilead Sciences, Juno Therapeutics, and Bluebird Bio are also investing in cell therapy research and development. These companies are working to develop treatments that can improve the quality of life for patients with a variety of diseases. Show Less Read more